Therefore, renalase deficiency suppresses lipid metabolism via the Akt–Srebf1 pathway and suggests a potential role in attenuating the hepatic lipid accumulation that precedes MASLD pathogenesis. The gene discussed is RNLS; the disease is metabolic dysfunction-associated steatotic liver disease.